KalVista Pharmaceuticals Inc (KALV)
12.13
-0.04
(-0.33%)
USD |
NASDAQ |
May 03, 16:00
12.14
+0.01
(+0.08%)
After-Hours: 20:00
KalVista Pharmaceuticals Market Cap: 511.74M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 511.74M |
| May 02, 2024 | 513.43M |
| May 01, 2024 | 513.85M |
| April 30, 2024 | 478.84M |
| April 29, 2024 | 464.49M |
| April 26, 2024 | 454.79M |
| April 25, 2024 | 442.56M |
| April 24, 2024 | 436.65M |
| April 23, 2024 | 472.93M |
| April 22, 2024 | 482.63M |
| April 19, 2024 | 488.12M |
| April 18, 2024 | 485.17M |
| April 17, 2024 | 491.49M |
| April 16, 2024 | 501.20M |
| April 15, 2024 | 495.29M |
| April 12, 2024 | 501.62M |
| April 11, 2024 | 510.48M |
| April 10, 2024 | 503.31M |
| April 09, 2024 | 498.24M |
| April 08, 2024 | 465.76M |
| April 05, 2024 | 467.87M |
| April 04, 2024 | 472.93M |
| April 03, 2024 | 475.04M |
| April 02, 2024 | 465.76M |
| April 01, 2024 | 480.95M |
| Date | Value |
|---|---|
| March 28, 2024 | 500.35M |
| March 27, 2024 | 467.02M |
| March 26, 2024 | 468.71M |
| March 25, 2024 | 469.56M |
| March 22, 2024 | 499.93M |
| March 21, 2024 | 512.59M |
| March 20, 2024 | 515.96M |
| March 19, 2024 | 499.51M |
| March 18, 2024 | 505.84M |
| March 15, 2024 | 503.31M |
| March 14, 2024 | 524.40M |
| March 13, 2024 | 526.93M |
| March 12, 2024 | 526.93M |
| March 11, 2024 | 552.67M |
| March 08, 2024 | 605.82M |
| March 07, 2024 | 582.26M |
| March 06, 2024 | 597.85M |
| March 05, 2024 | 581.22M |
| March 04, 2024 | 583.30M |
| March 01, 2024 | 587.87M |
| February 29, 2024 | 567.50M |
| February 28, 2024 | 556.69M |
| February 27, 2024 | 607.83M |
| February 26, 2024 | 569.16M |
| February 23, 2024 | 523.01M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
103.33M
Minimum
Oct 19 2022
1.019B
Maximum
Feb 16 2021
341.56M
Average
314.79M
Median
Oct 18 2023
Market Cap Benchmarks
| Haemonetics Corp | 4.794B |
| Perspective Therapeutics Inc | 1.062B |
| Electromed Inc | 159.20M |
| Xtant Medical Holdings Inc | 110.68M |
| Asensus Surgical Inc | 65.55M |
Market Cap Related Metrics
| PS Ratio | 32.94 |
| PEG Ratio | -0.4534 |
| Price to Book Value | 5.777 |
| Price | 12.13 |
| Earnings Yield | -25.97% |
| PEGY Ratio | -0.4534 |